相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The epidemiology of non-alcoholic fatty liver disease
Stefano Bellentani
LIVER INTERNATIONAL (2017)
The burden of clostridium difficile infection: estimates of the incidence of CDI from US Administrative databases
Margaret A. Olsen et al.
BMC INFECTIOUS DISEASES (2016)
Marijuana Use and Type 2 Diabetes Mellitus: a Review
Stephen Sidney
CURRENT DIABETES REPORTS (2016)
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation
F. Rossi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies
A. Katrina Loomis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Secondary analysis of large databases for hepatology research
Philip N. Okafor et al.
JOURNAL OF HEPATOLOGY (2016)
A Systematic Review of the Respiratory Effects of Inhalational Marijuana
Mary P. Martinasek et al.
RESPIRATORY CARE (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Relationships Between Alanine Aminotransferase, Serum Triglycerides, Body Mass Index and Nonalcoholic Fatty Liver Disease in an Outpatient Pediatric Clinic Population
Deborah Cohen et al.
JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Exercise and improvement of NAFLD: Practical recommendations
Rohit Loomba et al.
JOURNAL OF HEPATOLOGY (2015)
Effect of aerobic exercise training dose on liver fat and visceral adiposity
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2015)
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice
Michal Ganz et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
The Epidemiology of Obesity: A Big Picture
Adela Hruby et al.
PHARMACOECONOMICS (2015)
The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: A cross-sectional population-based study in Saskatchewan, Canada
Yelena Bird et al.
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2015)
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review
Maureen Whitsett et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Non-alcoholic fatty liver disease - the heart of the matter
Haneen Azzam et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
The Patient Protection and Affordable Care Act: opportunities for prevention and public health
Frederic E. Shaw et al.
LANCET (2014)
Nonalcoholic fatty liver disease and aging: Epidemiology to management
Marco Bertolotti et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A cceleration training for managing nonalcoholic fatty liver disease: a pilot study
Sechang Oh et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2014)
The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
Elizabeth A. Penner et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Amedeo Lonardo et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)
Temitope Foster et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
Zobair M. Younossi et al.
MEDICINE (2012)
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III
Tripathi B. Rajavashisth et al.
BMJ OPEN (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Obesity and Cannabis Use: Results From 2 Representative National Surveys
Yann Le Strat et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Poverty and Obesity in the U.S.
James A. Levine
DIABETES (2011)
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
Kate Hallsworth et al.
GUT (2011)
Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study
Takumi Kawaguchi et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
Jonel Trebicka et al.
LIVER INTERNATIONAL (2011)
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Dina G. Tiniakos et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Epidemiology of Non-Alcoholic Fatty Liver Disease
Stefano Bellentani et al.
DIGESTIVE DISEASES (2010)
Suspected Nonalcoholic Fatty Liver Disease Is Not Associated with Vitamin D Status in Adolescents after Adjustment for Obesity
Karin Katz et al.
JOURNAL OF OBESITY (2010)
Are adolescents who moderate their cannabis use at lower risk of later regular and dependent cannabis use?
Wendy Swift et al.
ADDICTION (2009)
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
Barbara Batetta et al.
JOURNAL OF NUTRITION (2009)
Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
Kirsten R Müller-Vahl et al.
Expert Review of Neurotherapeutics (2008)
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
Michael Charlton
HEPATOLOGY (2008)
Understanding and enhancing the value of hospital discharge data
Julie A. Schoenman et al.
MEDICAL CARE RESEARCH AND REVIEW (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Fatty liver, carotid disease and gallstones: A study of age-related associations
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults
Chien-Hua Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
JH Allen et al.
GUT (2004)
Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
S Kojima et al.
JOURNAL OF GASTROENTEROLOGY (2003)
分享论文
